Ellis Andrea

Ellis Andrea is listed in filings as Director at BridgeBio Pharma, Inc. - Common Stock. This profile follows SEC Form 4 activity through Mar 6, 2026, including sale activity. Recent filings connect the profile to BridgeBio Pharma, Inc. - Common Stock (BBIO). The current snapshot covers public activity from Apr 3, 2025 to Mar 6, 2026. Reported amounts are shown as $1.0M to $350.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.